Effect of insulin and metformin on methylation and glycolipid metabolism of peroxisome proliferator-activated receptor γ coactivator-1A of rat offspring with gestational diabetes mellitus  by Song, Ai-Qin et al.
HOSTED BY Contents lists available at ScienceDirect
Asian Paciﬁc Journal of Tropical Medicine 2016; 9(1): 91–95 91Asian Paciﬁc Journal of Tropical Medicine
journal homepage: http://ees.elsevier.com/apjtmOriginal research http://dx.doi.org/10.1016/j.apjtm.2015.12.018*Corresponding author: Ai-Qin Song, M.M., Deputy Attending Physician,
Department of Pediatric Hematology, Afﬁliated Hospital of Qingdao University,
Qingdao 266003, Shandong, China.
Tel: +86 18661807987
E-mail: 18661807987@163.com
Peer review under responsibility of Hainan Medical College.
Foundation project: It was supported by Shandong Natural Science Fund
(Y2008c170).
1995-7645/Copyright © 2016 Hainan Medical College. Production and hosting by Elsevier B.V. This is an open access a
creativecommons.org/licenses/by-nc-nd/4.0/).Effect of insulin and metformin on methylation and glycolipid metabolism of peroxisome proliferator-
activated receptor g coactivator-1A of rat offspring with gestational diabetes mellitusAi-Qin Song*, Li-Rong Sun, Yan-Xia Zhao, Yan-Hua Gao, Lei ChenDepartment of Pediatric Hematology, Afﬁliated Hospital of Qingdao University, Qingdao 266003, Shandong, ChinaARTICLE INFO
Article history:
Received 15 Oct 2015
Received in revised form 20 Nov
2015
Accepted 3 Dec 2015
Available online 18 Dec 2015
Keywords:
Insulin
Metformin
Gestational diabetes mellitus
Peroxisome proliferator-activated
receptor g coactivator-1A
Methylation
Glycolipid metabolismABSTRACT
Objective: To discuss the effect of insulin and metformin on a methylation and glyco-
lipid metabolism of peroxisome proliferator-activated receptor g coactivator-1A
(PPARGC1A) of rat offspring with gestational diabetes mellitus (GDM).
Methods: A total of 45 pregnant rats received the intraperitoneal injection of streptozo-
tocin to establish the pregnant rat model of GDM. A total of 21 pregnant rats with GDM
were randomly divided into three groups, with 7 rats in each group, namely the insulin
group, metformin group and control group. Rats in the insulin group received the
abdominal subcutaneous injection of 1 mL/kg recombinant insulin glargine at 18:00 every
day. Rats in the metformin group received the intragastric infusion of metformin hydro-
chloride at 18:00 every day, with the ﬁrst dose of 300 mg/kg. The doses of two groups were
adjusted every 3 d to maintain the blood glucose level at 2.65–7.62 mmol/L. Rats in the
control group received the intragastric infusion of 1 mL normal saline at 18:00 every day.
After the natural delivery of pregnant rats, 10 offspring rats were randomly selected from
each group. At birth, 4 wk and 8 wk after the birth of offspring rats, the weight of offspring
rats was measured. The blood glucose level of offspring rats was measured at 4 wk and
8 wk, while the level of serum insulin, triglyceride and leptin was measured at 8 wk.
Results: The weight of offspring rats at birth in the insulin group and metformin group was
signiﬁcantly lower than the one in the control group (P < 0.05), and there was no signiﬁcant
difference at 4 wk and 8 wk among three groups (P > 0.05). The fasting blood glucose and
random blood glucose in the insulin group and metformin group at 4 wk and 8 wk were all
signiﬁcantly lower than ones in the control group (P < 0.05); there was no signiﬁcant dif-
ference between the insulin group and metformin group (P > 0.05). The expression of
PPARGC1AmRNAin the insulin group andmetformin groupwas signiﬁcantly higher and the
methylation level of PPARGC1A was signiﬁcantly lower than the one in the control group
(P < 0.05); but there was no signiﬁcant difference between the insulin group and metformin
group (P > 0.05). Insulin and leptin at 8 wk in the insulin group and metformin group were
signiﬁcantly higher, while triglyceride was signiﬁcantly lower than the one in the control
group (P<0.05); triglyceride level in the insulin groupwas signiﬁcantly higher than the one in
themetformin group (P< 0.05). There was no signiﬁcant difference in insulin and leptin level
between the insulin group and metformin group (P > 0.05).
Conclusions: GDM can induce the methylation of PPARGC1A of offspring rats to
reduce the expression of PPARGC1A mRNA and then cause the disorder of glycolipid
metabolism when the offspring rats grow up; the insulin or metformin in the treatment of
pregnant rats with GDM can reduce the methylation level of PPARGC1A and thus
improve the abnormal glycolipid metabolism of offspring rats.rticle under the CC BY-NC-ND license (http://
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The gestational diabetes mellitus (GDM) refers to the hy-
perglycemia of pregnant woman who has no diabetes mellitus
before the pregnancy. A survey indicated that [1] over 80% of
pregnant women with diabetes mellitus was GDM, while the
diabetes mellitus combined with pregnancy occupied less than
20%. As GDM usually occurs in the third trimester, the long-
term hyperglycemia could increase the risk of metabolic dis-
eases for the fetus [2,3]. A foreign scholar [4] reported that the
peroxisome proliferator-activated receptor g coactivator-1A
(PPARGC1A) was the main transcription factor involved in
the regulation of mitochondria metabolism, while the methyl-
ation degree of PPARGC1A was related to the occurrence and
development of metabolic diseases of the offspring. According
to a previous research [5], the effect of PPARGC1A on the
secretion of human insulin was controlled by the genetics and
external environment. Thus the external stimulation to change
the methylation of PPARGC1A is of critical importance in
controlling the occurrence of metabolic diseases. In this study,
GDM rats received the interventional treatment of insulin and
metformin respectively to discuss the methylation of
PPARGC1A of the offspring rats and the effect of earlier
intervention of hypoglycemic drugs on the metabolic diseases
of offspring rats from the aspect of action mechanism. The
ﬁndings are shown as follows.2. Materials and methods
2.1. Laboratory animals
A total of 45 Sprague–Dawley rats were purchased from the
laboratory animal of hospital, including 30 females and 15
males. All of them were unmated rats aged 8 wk. The weight of
male rats was 280–310 g, with the average of (303.5 ± 10.4) g;
while the weight of female rats was 200–240 g, with the average
of (228.7 ± 9.7) g. All rats were fed with diet and water freely.
The room temperature was maintained at 20–22 C; the feeding
was taken under 12 h of lighting and 12 h of darkness. The
experiment was performed 1 wk later.2.2. Methods
2.2.1. Rat model of GDM
The female and male rats were mated in the cage by the ratio
of 2: 1. They were observed in the next morning. The observed
vaginal suppository of female rats indicated Day 1 of pregnancy.
A total of 27 rats in this group had successful pregnancy. Female
rats with the success of pregnancy began the fasting for 12 h at
Day 7 of pregnancy. The pregnant rats were given the intra-
peritoneal injection of streptozotocin (which was purchased
from Shanghai Shifeng Biological Technology Co., Ltd., batch
No. 130921), with the dose of 30 mg/kg. The blood was
collected from the tails 48 h later using Accu-Chek Blood
Glucose Monitoring Meter (Roche Diagnostics Shanghai Ltd.)
to detect the blood glucose level of rats. The blood glucose
14 mmol/L was regarded as the successful rat modeling of
GDM. A total of 21 rats in this group had successful modeling.
Pregnant rats with GDM were randomly divided into three
groups, with 7 rats in each group, namely the insulin group,
metformin group and control group.2.2.2. Drug administration
Insulin group: rats were given the abdominal subcutaneous
injection of 0.1 mL/kg recombinant insulin glargine (which was
purchased from Gan & Lee Pharmaceuticals, batch No. 121103,
3 mL: 300 units/piece) at 18:00 every day. The fasting blood
glucose was detected in tails at 8:00 the next day. Referring to
the related researches [6], the insulin dose was adjusted
according to the blood glucose level every 3 d and the blood
glucose level was maintained at 2.65–7.62 mmol/L. Metformin
group: rats were given the intragastric infusion of metformin
hydrochloride (which was purchased from Shanghai Sine
Tianping Pharmaceutical, batch No. 130125, 0.25 g/tablet) at
18:00 every day, with the ﬁrst dose of 300 mg/kg. The fasting
blood glucose was detected in tails at 8:00 the next day. The
metformin dose was adjusted according to the blood glucose
level every 3 d and the blood glucose level was maintained at
2.65–7.62 mmol/L. Control group: rats were given the
intragastric infusion of 1 mL normal saline at 18:00 every day
and the blood glucose level was detected. In this study, only 1
rat in the insulin group and 2 rats in the metformin group had
the blood glucose level before the delivery that beyond the
standard range; while 2 rats in the control group died because
of the high blood glucose. Pregnant rats with unqualiﬁed
blood glucose level or died ones were excluded from this
study. The remained 16 rats had the normal delivery. The
offspring rats were fed by female rats regularly. The normal
breeding began 3 wk later, while the experiment was taken
8 wk later. 1 offspring rat (insulin group) with the high birth
weight (>10 g) and 2 offspring rats (1 in the metformin group
and 1 in the control group) with the low birth weight (<5 g)
were excluded from this study. Ten offspring rats were
randomly chosen from each group for the experiment.
2.2.3. Offspring rat
The blood glucose and weight of offspring rats were measured
at birth, 4 wk and 8 wk after the birth. The electronic balance
(model: FA2004N, Nanjing Kehang Experimental Instruments
Co., Ltd.) was employed to detect the body mass of offspring rats.
The tail-docking blood sampling method was employed to detect
the blood glucose at the 3rd week, while the heart puncture was
adopted to detect the blood glucose at the 8th week.
2.2.4. Detection of serum biochemical indicator
At the 8th week, the offspring rats were anesthetized with the
chloral hydrate. With the conventional thoracotomy, the venous
blood was sampled by 2 mL and then centrifuged at 12000 r/min
for 10 min. The collected serum was stored in the refrigerator
at −80 C for the detection. Meanwhile, the pancreatic tissues
were collected from offspring rats and then stored in the
refrigerator at −80 C for the detection. After sampling the
serum from offspring rats, the enzyme-linked immunosorbent
assay was employed to detect the level of serum insulin (INS),
triglyceride (TG) and leptin (LP) in offspring rats. The related
testing kit was provided by Shanghai Pumai Biotechnology Co.,
Ltd. The detection should be performed in accordance with the
instruction manual of kit.2.2.5. Detection of PPARGC1A mRNA
Trizol (Nanjing SenBeiJia Biological Technology Co., Ltd.)
was employed to extract the total RNA from the pancreatic
tissues and the reverse transcription kit was used to transcript it
Table 1
Primer sequence and product size.
Gene Primer sequence (50–30) Product size (bp)
PPARGC1A Upstream: CTCGTCACATCGAGGCGAATTC 185
Downstream: GTGCGCAAATGATTATGAGTTATGATCTG
Methylation of PPARGC1A Upstream: GTCGTCACTAGCAGGCGATTAG 189
Downstream: GCCGCAGGCCAATTCATTTAG
GAPDH Upstream: GAGTCTAGCCCGCTGCTGAATC 160
Downstream: GCAGGATGAATGCTGCATGATA
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chain reaction (PCR) was adopted to detect the PPARGC1A
mRNA. The primers were synthesized by Shanghai Generay
Biotech Co., Ltd. The PCR reaction system was: 10 mL Power
SYBR Green PCR Master Mix, 1 mL primers, 3 mL cDNA
and 15 mL ddH2O; taking GAPDH as the reference, the primer
sequence was shown in Table 1. PCR reaction conditions
included: predegeneration at 95 C for 5 min, degeneration
at 97 C for 30 s and annealing at 60 C for 30 s, with 35
cycles in total. After PCR reaction, the melting curve was
adopted for the analysis. Each sample had 3 repeated holes to
calculate the average. The relative expression of target
gene = −2−△Ct.
2.2.6. Methylation of PPARGC1A DNA
DNA extraction kit (Nanjing SenBeiJia Biological Technol-
ogy Co., Ltd.) was used to extract the total DNA from pancreatic
tissues of pregnant rats. The restriction enzyme HinII (Thermo)
that was sensitive to the methylation was employed to digest the
sample DNA. DNA templates before and after the restriction
endonuclease digestion were ampliﬁed with PPARGC1A and
GAPDH respectively. The PCR reaction system was: 10 mL
Power SYBR Green PCR Master Mix, 1 mL primers, 2.5 mL
DNA templates and 15 mL ddH2O. PCR reaction conditions
included: predegeneration at 95 C for 5 min, degeneration at
97 C for 30 s and annealing at 60 C for 30 s, with 35 cycles in
total. The relative expression of target gene was calculated using
△Ct method, where △Ct = △CtPPARGC1A − △CtGAPDH and
methylation index = −2−△△Ct.
2.3. Statistical analysis
SPSS 19.0 was employed for the statistical analysis. The
measurement data was expressed by mean ± standard deviation.
The analysis of variance was chosen for the multiple-group
comparison, while LSD test was used for the comparison be-
tween means. P < 0.05 indicated the signiﬁcant difference.Table 2
Comparison of body mass and blood glucose level between three groups.
Group Cases Body mass (g)
At birth 4th week 8th week
Insulin group 10 5.5 ± 0.5 49.7 ± 7.6 257.4 ± 21
Metformin group 10 5.6 ± 0.7 48.9 ± 5.7 248.5 ± 17
Control group 10 7.5 ± 0.3 51.2 ± 9.3 245.8 ± 14
F value 18.362 0.231 1.143
P value 0.001 0.795 0.3353. Results
3.1. General information of offspring rats
There were 31 offspring rats in the insulin group, 29 in the
metformin group and 37 in the control group. Except 7 offspring
rats died in the control group, all other offspring rats survived
normally. The offspring rats in each group had no obvious
deformity in the appearance, with the good situation of growth
and development.
3.2. Comparison of body mass and blood glucose level
The body mass for offspring rats at birth in the insulin
group and metformin group was signiﬁcantly lower than the
one in the control group (P < 0.05). There was no signiﬁcant
difference in the body mass 4 wk and 8 wk after the birth of
offspring rats between three groups (P > 0.05). The fasting
blood glucose and random blood glucose for offspring
rats in the insulin group and metformin group at 4th week
and 8th week after the birth were signiﬁcantly lower than
ones in the control group (P < 0.05). There was no
signiﬁcant difference in the blood glucose level between the
insulin group and metformin group (P > 0.05), as shown in
Table 2.
3.3. Comparison of expression of PPARGC1A mRNA
and methylation level
The expression of PPARGC1A mRNA for offspring rats in
the insulin group and metformin group was signiﬁcantly higher
than the one in the control group, while the methylation level
was signiﬁcantly lower than the one in the control group
(P < 0.05). There was no signiﬁcant difference in the expression
of PPARGC1A mRNA and methylation level between the in-
sulin group and metformin group (P > 0.05), as shown in
Table 3.Fasting blood glucose
(mmol/L)
Random blood glucose
(mmol/L)
4th week 8th week 4th week 8th week
.3 5.37 ± 1.03 6.01 ± 1.32 7.09 ± 0.85 7.58 ± 0.59
.4 5.24 ± 0.79 5.98 ± 1.17 6.94 ± 0.78 7.39 ± 0.43
.6 8.18 ± 0.85 10.65 ± 1.85 14.02 ± 3.49 15.43 ± 4.42
13.753 13.274 14.531 12.593
0.002 0.002 0.001 0.003
Table 3
Comparison of expression of PPARGC1A mRNA and methylation level.
Group Cases Expression of
PPARGC1A mRNA
Methylation level of
PPARGC1A
Insulin
group
10 1.218 ± 0.219 0.027 ± 0.010
Metformin
group
10 1.197 ± 0.176 0.026 ± 0.008
Control
group
10 0.487 ± 0.038 0.739 ± 0.174
F value 64.620 66.713
P value 0.000 0.000
Table 4
Comparison of serum biochemical indicator.
Group Cases INS (mU/L) TG (mmol/L) LP (mg/L)
Insulin group 10 8.21 ± 1.37 1.96 ± 0.37 7.89 ± 0.79
Metformin group 10 8.27 ± 1.25 1.59 ± 0.41 8.07 ± 0.81
Control group 10 6.03 ± 0.69 2.31 ± 0.76 5.43 ± 0.28
F value 12.482 4.406 48.043
P value 0.001 0.022 0.000
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INS and LP for offspring rats at 8 wk in the insulin group and
metformin group were signiﬁcantly higher than ones in the
control group, while TG was signiﬁcantly lower than the one in
the control group (P < 0.05). TG level in the insulin group was
signiﬁcantly higher than the one in the metformin group
(P < 0.05). There was no signiﬁcant difference in INS and LP
level between the insulin group and metformin group (P > 0.05),
as shown in Table 4.
4. Discussion
According to a previous research [7], the abnormal
intrauterine environment would induce the fetus to form the
certain genetic memory and then cause the signiﬁcantly higher
incidence of some metabolic diseases in adulthood. The
gestational diabetes mellitus is the common complication for
pregnant women. The epidemiological survey [8] indicated that
the blood glucose level for the newborns delivered by GDM
pregnant women would be higher than the normal infants,
with the increased risk of diseases such as the diabetes
mellitus in adulthood. Luo et al. [9] adopted the streptozotocin
to prepare the rat model of GDM. The results showed that the
birth weight of offspring rats of GDM was about 2.1 times
heavier than the one of common offspring rats. Besides, the
birth weight of offspring rats of GDM would be signiﬁcantly
increased during the observation. In consequence, the decrease
in the blood glucose level of GDM pregnant women would be
of critical importance for the prognosis of the newborns. The
effect mechanism of GDM on the fetus has not been fully
understood for the moment. Though some domestic research
[10] reported that the metabolic disorder of offspring might be
related to the malnutrition or hypernutrition of fetus, some
evidence [11] indicated that the mechanism of epigenetic
regulation played a key role in the metabolic diseases of fetus
caused by GDM. The methylation of DNA is the main way to
regulate the epigenetics, which is mainly involved inregulating the integrity of DNA, genetic mutation and
chromatin modiﬁcation. However the methylation of DNA
was extremely sensitive to the external environmental factors
[12], as the proper external stimulation could regulate the
methylation of DNA. PPARGC1A is the main transcription
factor to regulate the mitochondria metabolism. Gillberg [13]
found that in the human pancreatic tissues, the methylation
level of CpG island in the promoter of PPARGC1A could
reﬂect the metabolic regulation of body. Therefore, this study
proposed the following hypothesis in the beginning of design:
the intervention of hypoglycemic drugs in the gestation of
GDM pregnant women could reduce the methylation level of
PPARGC1A in GMD patients to regulate the hyperglycemia
environment in vivo and then improve the prognosis of
offspring.
To prove the above hypothesis, GDM rats were given the
subcutaneous injection of insulin and intragastric infusion of
metformin respectively. Compared with the control group, the
results showed that the body mass of offspring rats at birth in the
insulin group and metformin group was signiﬁcantly lower than
the one in the control group, but there was no signiﬁcant dif-
ference in the weight of offspring rats at the 4th and 8th week
after the birth between three groups. During the gestation of
GDM pregnant rats, the embryo was in the condition of hy-
perglycemia to cause the accumulation of subcutaneous fat and
increase of weight. The drug intervention could reduce the
condition of hyperglycemia of GDM pregnant rats, while the
birth weight of embryo in the relatively normal environment
would not be increased signiﬁcantly. After the delivery, the
offspring rats left the environment of hyperglycemia and then
the increase in the weight was slowed, which indicated that the
weight of offspring might be decided by the external factors and
intrauterine environment. The further study on the blood glucose
level of offspring rats showed that the fasting blood glucose and
random blood glucose for offspring rats at the 4th and 8th week
after the birth in the insulin group and metformin group were
signiﬁcantly lower than ones in the control group. Zeng et al.
[14] reported that the b cell damage during the gestation of
pregnant rats would cause the b cell damage of offspring rats
and such damage might be continued to the adulthood and
form the permanent insulin resistance of offspring rats. Lei
et al. [15] also found that even the offspring rats left the
environment of hyperglycemia, its b cells could not be
recovered to the normal level. Referring to the ﬁndings of this
study, the drug intervention could reduce the degree of b cell
damage to improve the intrauterine hyperglycemia level, then
the b cell function of offspring and ﬁnally the insulin
resistance of offspring.
The long-term intrauterine hyperglycemia level of GDM
would change the epigenetics through the methylation of
PPARGC1A DNA [16,17], which would thus increase the risk of
diabetes mellitus for offspring rats. In this study, the results
showed that the expression of PPARGC1A mRNA for
offspring rats in the insulin group and metformin group was
signiﬁcantly higher than the one in the control group, while
the methylation level of PPARGC1A was signiﬁcantly lower
than the one in the control group, which indicated that the
drug intervention could reduce the methylation of
PPARGC1A, increase the expression of PPARGC1A mRNA,
and thus reduce the intrauterine hyperglycemia environment of
GDM pregnant rats, reverse the epigenetics and ﬁnally
improve the metabolic level of offspring rats. Franks [18] also
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pancreatic tissues and skeletal muscle of patients with diabetes
mellitus was signiﬁcantly lower than the one in the normal
group, while the expression of PPARGC1A mRNA was
closely related to the methylation level of such gene. It
indicated that the decrease in the methylation of PPARGC1A
and improvement on the intrauterine blood glucose were of
signiﬁcance to reduce the risk of metabolic diseases of
offspring such as the diabetes mellitus. LP is the protein
product of obese gene released by the adipose tissue, while LP
level is negatively correlated to the fat storage. Morteza [19]
reported that the absence of LP and receptor could increase
the incidence of early obesity. In this study, LP level in the
insulin group and metformin group was signiﬁcantly higher
than the one in the control group, which indicated that the
drug intervention could increase the secretion of LP to reduce
the birth weight, which was in consistent with the ﬁnding that
the birth body weight for offspring rats in the insulin group
and metformin group was signiﬁcantly lower than the one in
the control group. Su [20] found that GDM pregnant women
would have the higher incidence of high TG of offspring. It
was because there was the steep concentration gradient of TG
in the blood circulation of GDM pregnant women and TG was
accelerated to be transferred to the fetal tissue through the
placenta. In this study, TG level in the insulin group and
metformin group was signiﬁcantly lower than the one in the
control group, which proved that the drug intervention could
reduce the transfer of TG from the pregnant rats to the
offspring. Besides, it also found that the TG level in the
insulin group was signiﬁcantly higher than the one in the
metformin group, which might be related to the different
mechanism of insulin and metformin. The metformin can
reduce the plasma TG and cholesterol level and can also act
on the offspring rat through the placental barrier after the
intragastric infusion to obviously reduce the TG level in
offspring rats [21].
In conclusion, GDM can induce the methylation of
PPARGC1A in offspring rats to reduce the expression of
PPARGC1A mRNA; it will then cause the disorder of glycolipid
metabolism of offspring in the adulthood. The treatment of in-
sulin or metformin in GDM pregnant rats can reduce the
methylation level of PPARGC1A and thus improve the abnormal
glycolipid metabolism of offspring rats. At present, there are
limited researches on such drug intervention in the human,
because the drug intervention during the pregnancy may have
the certain risk. The effect of drug intervention on the safety of
offspring will be deeply analyzed in the further studies.
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